 |
Richard N. Spivey, PharmD, PhD
Senior Vice President, Research and Development
|
Richard N. Spivey, PharmD, PhD, Senior Vice President, Research and Development oversees the Company’s worldwide medical, regulatory, product/process development, and quality assurance programs. He brings to MedPointe an outstanding background in pharmaceutical product development and regulatory affairs spanning more than twenty years at leading pharmaceutical companies, including most recently Pharmacia/Searle, and earlier, Warner-Lambert and Schering-Plough. In his most recent position (2001-2002) at Pharmacia Corp., he reported to the corporation’s CEO as its SVP-Corporate Technical Policy. Immediately prior thereto and upon Searle’s merger into Pharmacia in 2000, Dr. Spivey was named SVP-Global Regulatory Affairs at Pharmacia, where he led the combined company’s worldwide regulatory activities, including direct oversight of 250 staff at three R&D locations and several development centers. At Searle, as VP-WW Regulatory Affairs (1996-2000), he steered the strategic regulatory development of Searle’s portfolio, including the filing, labeling and global approval of its arthritis medication, Celebrex, and its follow-up compound, Bextra. His regulatory experience includes extensive interaction with the world’s most influential pharmaceutical regulatory agencies; e.g., FDA, HPB, EMEA, CPMP, and TGA. While at Pharmacia, he also served as Chairman of the Pharmaceutical Research and Manufacturers of America’s (PhRMA) Regulatory Affairs Committee.
From 1990-1996, Dr. Spivey served in a series of successively more senior Regulatory Affairs positions at Warner-Lambert (1990-1992) and Schering-Plough (1993-1996). He began his business career in 1985 as a Clinical Investigation Manager at Boehringer Ingelheim where he led several Phase IV research programs.
Prior to his career in the pharmaceutical industry, Dr. Spivey was engaged in various academic pursuits, including an assistant professorship at the College of Pharmacy at Washington State University and a Research Associate post at Tufts’ Center for the Study of Drug Development.
Dr. Spivey obtained his PharmD from the University of Southern California and earned his PhD in Pharmacy Administration from the University of Minnesota.
Meda Pharmaceuticals